Document type
ArticleVersion
Accepted versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/121061
Direct evidence of the presence of cross-linked Aβ dimers in the brains of Alzheimer's disease patients
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Brain-derived amyloid-β (Aβ) dimers are associated with Alzheimer´s disease (AD). However, their covalent nature remains controversial. This feature is relevant, as a covalent cross-link would make brain-derived dimers (brain dimers) more synaptotoxic than Aβ monomers and would make them suitable candidates for biomarker development. To resolve this controversy, we here present a three-step approach. First, we validated a type of synthetic cross-linked Aβ (CL Aβ) dimers, obtained by means of the photo-induced cross-linking of unmodified proteins (PICUP) reaction, as well-defined mimics of putative brain CL Aβ dimers. Second, we used these PICUP CL Aβ dimers as standards to improve the isolation of brain Aβ dimers and to develop state-of-the-art mass spectrometry (MS) strategies to allow their characterization. Third, we applied these MS methods to the analysis of brain Aβ dimer samples allowing the detection of the CL [Aβ(6-16)]2 peptide comprising a dityrosine cross-link. This result demonstrates the presence of CL Aβ dimers in the brains of patients with AD and opens up avenues for establishing new therapeutic targets and developing novel biomarkers for this disease.
Subject (English)
Citation
Citation
VÁZQUEZ DE LA TORRE CERVERA, Aurelio, et al. Direct evidence of the presence of cross-linked Aβ dimers in the brains of Alzheimer's disease patients. Analytical Chemistry. 2018. [consulted: 13 of June of 2026]. Available at: https://hdl.handle.net/2445/121061